Avoid Errors With the New Strength of Xarelto

December 2018

You might see more patients getting the direct oral anticoagulant (DOAC) Xarelto (rivaroxaban)...due to a new 2.5 mg strength and indication.

Xarelto will still be used to prevent or treat blood clots...and to reduce strokes in patients with atrial fibrillation, or an irregular heartbeat.

But now some patients with heart disease or poor blood flow to the limbs may take the new 2.5 mg tab plus aspirin...to reduce the risk of heart attack, stroke, and cardiovascular death.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Communication Up Your Communication Game With "SBAR"
Migraine Help Migraine Patients Get Needed Meds Right Away
Operations & Management Take Stock of Expiring or Excess Inventory
Antibiotics Think of Eravacycline as Similar to Tigecycline
Biosimilars Clear Up Confusion About Biosimilars
Raynaud's Know How Treatments for Raynaud's Phenomenon Stack Up
Influenza Xofluza Will Be a New Antiviral to Treat the Flu
Hemophilia Jivi and Rebinyn Will Be New Clotting Factors for Hemophilia
Antithrombotics Avoid Errors With the New Strength of Xarelto

Avoid Errors With the New Strength of Xarelto

Practical advice for a better career, with unlimited access to CE

Table of Contents